S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
OTCMKTS:ABSCF

AB Science Stock Forecast, Price & News

$18.96
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.96
Now: $18.96
$18.96
50-Day Range
$18.22
MA: $19.62
$20.75
52-Week Range
$6.90
Now: $18.96
$26.70
VolumeN/A
Average Volume1,417 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AB Science S.A., a clinical-stage pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase II clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France.

Headlines

Does AB Science S.A. (EPA:AB) Have A High Beta?
May 27, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ABSCF
CUSIPN/A
CIKN/A
Phone33 1 47 20 00 14
Employees93
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.76 out of 5 stars

Medical Sector

1181st out of 1,972 stocks

Drug Manufacturers—Specialty & Generic Industry

26th out of 67 stocks

Analyst Opinion: 0.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$18.96
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABSCF News and Ratings via Email

Sign-up to receive the latest news and ratings for ABSCF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AB Science (OTCMKTS:ABSCF) Frequently Asked Questions

Is AB Science a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AB Science in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AB Science stock.
View analyst ratings for AB Science
or view top-rated stocks.

What stocks does MarketBeat like better than AB Science?

Wall Street analysts have given AB Science a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AB Science wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are AB Science's key executives?

AB Science's management team includes the following people:
  • Mr. Alain Moussy, Co-Founder, Chairman, Pres, CEO & Scientific Director
  • Mr. Denis Gicquel, Head of Pharmaceutical Devel.
  • Mr. Laurent Guy MBA, Chief Financial Officer
  • Mr. Christian FASSOTTE, Global Chief Medical Officer
  • Mr. Alexis BERNARD, Head of Veterinary Sales
  • Ms. Catherine ARGILLIER, Head of Quality Assurance
  • Ms. Edita DOLIMIER, Head of Clinical Devel.
  • Mr. Harshad KULKARNI, Head of Statistics
  • Mr. Antonello CERVONE, Head of Data Management & IT Director
  • Dr. Yves Grumser M.D., Head of Clinical Safety & Pharmacovigilance

Who are some of AB Science's key competitors?

What is AB Science's stock symbol?

AB Science trades on the OTCMKTS under the ticker symbol "ABSCF."

How do I buy shares of AB Science?

Shares of ABSCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AB Science's stock price today?

One share of ABSCF stock can currently be purchased for approximately $18.96.

How many employees does AB Science have?

AB Science employs 93 workers across the globe.

What is AB Science's official website?

The official website for AB Science is www.ab-science.com.

How can I contact AB Science?

The company can be reached via phone at 33 1 47 20 00 14.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.